DossierENTITY

Vivani Medical

Coverage of Vivani Medical in the Nexus archive.

Earliest in view: Jul 11 · 12:00 UTCMost recent: Jul 11 · 12:00 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHJul 11 · 12:00 UTCCNBC TOP
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
Vivani Medical is developing an implant containing semaglutide, the active ingredient in Novo Nordisk's obesity treatment Wegovy and diabetes drug Ozempic, as a new approach to help patients maintain weight loss.